Pfizer Inc.'s suspension of sales of its painkiller Bextra is likely to open the drugmaker to more product liability lawsuits, lawyers said on Thursday.

"There will be a stampede of lawsuits," said Matt Zapf, head of product liability at the Chicago law firm of Goldberg Kohn.

"We've had Bextra cases coming in for years on Stevens Johnson Syndrome," said Kimberly Wilson, an attorney at the Raleigh, North Carolina, firm of Lewis & Roberts. She referred to the potentially life-threatening skin allergy that Bextra has been associated with.

The cases are under review, but the law firm is definitely going to file at least one Bextra lawsuit, she said.
Officials at Pfizer were not immediately available to comment on how many lawsuits the company has been served involving Bextra or Celebrex, a similar, older drug.

Bextra and Celebrex belong to a class of drugs called COX-2 inhibitors that also includes Merck & Co.'s Vioxx, which was voluntarily withdrawn by the company last year after it was shown to increase the risk of stroke and heart attack.

Merck said last month it had been served with 1,357 Vioxx product liability lawsuits and expected many more.

Pfizer agreed to suspend sales of Bextra after the U.S. Food and Drug Administration and European regulators said the risk of serious side effects, including Stevens-Johnson Syndrome, outweighed the drug's benefits.

But the company said it disagreed with the regulatory decisions on Bextra, which had sales last year of $1.3 billion, and will explore options under which it might be allowed to resume sales of the drug.

"The FDA should have done this months ago considering all of the information they had access to," Jere Beasley, a principal at the Montgomery, Alabama, law firm of Beasley Allen, which has filed some 58 lawsuits involving Vioxx, said in a statement.

Beasley Allen said it is currently reviewing more than 1,000 Bextra cases.

Its first trial against Pfizer regarding Vioxx is scheduled to begin on May 23, 2005 in Ashland, Alabama.


We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Bextra, Celebrex MDL judge sets first Bextra trial

On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the...

End Conflicts on FDA Approvals

In the coming weeks, the U.S. House and Senate will have to reconcile bills they passed that give the...

Frank Woodson on the Additional Costs and Hidden...

Frank Woodson and David Miceli discuss the additional costs and hidden dangers associated with COX-2...

Cox-2 Inhibitors

What are Cox-2 inhibitors? Our law firm has been in the forefront of the effort to have all of the...


What is Bextra? Bextra is valdecoxib-based drug that is administered orally. Bextra is used as...

Consumer Group says Celebrex Ad Downplays Risks

Pfizer had stopped advertising for the arthritis drug after Merck & Co. Inc.'s rival drug Vioxx was...

Lawyers and staff continue to help me

I suffered from an allergic reaction to a common medication causing permanent injury when I was 15 years old. My settlement allows me to take care of myself instead of being on disability. Even after my case was over, the lawyers and staff continue to help me.